Sensex
77,264.51 profit arw 330.92 (0.43%)
Nifty
24,175.65 profit arw 84.80 (0.35%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Enter a 10 digit mobile number starting with 7, 8, or 9
Captcha verification code, enter the characters shown below

As on : 26-Aug-2026
Corporate News
26-Aug-2026     20:40

Senores Pharmaceuticals appoints Dr. Shah as Director and approves ESOS 2026 for employees

Senores Pharmaceuticals Limited announced the appointment of Dr. Viranchi Arvindbhai Shah as a Director, bringing extensive experience in pharmaceuticals, policy, and international trade. The company also secured approval for the Senores Pharmaceuticals Employee Stock Option Scheme 2026 (ESOS 2026), granting 4,72,000 options to eligible employees, representing 1% of existing equity, with a potential discount of up to 50% on the market price. Furthermore, Senores Pharmaceuticals plans to incorporate a wholly-owned subsidiary in Mexico for pharmaceutical supply and distribution, and a subsidiary in Canada with at least 51% ownership, both requiring regulatory approvals and involving cash consideration.

INDIAN INDICES

Sensex

77,264.51 330.92 (0.43%)

Nifty

24,175.65 84.80 (0.35%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,584.80 19.05(0.07%)